During the past decade, New Brunswick Heart Centre conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Brunswick Heart Centre" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "St. Boniface Hospital" with 2 trials sponsored, "Alexion" with 1 trials sponsored, "Axio Research. LLC" with 1 trials sponsored and "Cubist Pharmaceuticals LLC" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Brunswick Heart Centre" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Foothills Medical Centre" with 1 trials as a collaborator, "Hamilton Health Sciences Corporation" with 1 trials as a collaborator, "London Health Sciences Centre" with 1 trials as a collaborator and "Mazankowski Alberta Heart Institute" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "New Brunswick Heart Centre" are "Coronary Artery Disease" (2 trials), "Acute Myocardial Infarction" (1 trials), "Anemia" (1 trials), "Angina Pectoris" (1 trials) and "Aortic Dissection" (1 trials). Many other conditions were trialed in "New Brunswick Heart Centre" in a lesser frequency.

Most popular intervention types in "New Brunswick Heart Centre" are "Drug" (7 trials), "Device" (2 trials), "Behavioral" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "DAPT (aspirin and/or P2Y12 receptor inhibitor)" (1 trials), "Extended arch repair" (1 trials), "Extended release niacin" (1 trials), "Hemiarch repair" (1 trials) and "Pexelizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "New Brunswick Heart Centre" are 12 trials for "All" genders.

Currently, there are NaN active trials in "New Brunswick Heart Centre". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in New Brunswick Heart Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in New Brunswick Heart Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".

New Brunswick Heart Centre has several departments that took part in Clinical trials: "Cardiology Research Associates of New Brunswick" - 2 trials